Moleculin Biotech, Inc. (MBRX) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Price / Book | 0.99 |
| FCF Yield | -151.0% |
| Altman Z-Score | -16.36 (distress) |
| Sector P/E (Healthcare) | 21.7 |
MBRX overview · MBRX earnings · MBRX KPIs · MBRX investor relations · MBRX ownership · MBRX peers · MBRX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.